Real‐world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single‐center retrospective study
- 6 March 2022
- journal article
- editorial
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (4) , 469-471
Abstract
No abstract availableKeywords
Funding Information
- Gunma University
This publication has 4 references indexed in Scilit:
- Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial RespondersJAMA Dermatology, 2021
- Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic DermatitisJAMA Dermatology, 2020
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrialsBritish Journal of Dermatology, 2020
- Diagnostic Features of Atopic DermatitisActa Dermato-Venereologica, 1980